Promising research on the use of palbociclib in the treatment of breast cancer
Promising research on the use of palbociclib in the treatment of breast cancer
Role of genomics in assessing risk, especially in ovarian cancer
Targeted Anti-cancer Therapies (TAT) conference roundup
I-SPY 2 trial shows promising development for some breast cancer patients using neratinib
Genetic testing can improve selection of women with ER positive breast cancer for ten rather than five years of hormonal therapy
EBCC 2014 key messages to doctors
Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer
The 1st Immunotherapy of Cancer Conference (ITOC)
Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer
Sharing Indian perspectives on CRPC
The future of mCRPC treatment - expert discussion
Insights into mCRPC in China, Thailand and Indonesia - expert discussion